Pharmacokinetic Imaging Using <sup>99m</sup>Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats

Endotoxemia-induced inflammation may impact the activity of hepatocyte transporters, which control the hepatobiliary elimination of drugs and bile acids. <sup>99m</sup>Tc-mebrofenin is a non-metabolized substrate of transporters expressed at the different poles of hepatocytes. <sup>...

Full description

Bibliographic Details
Main Authors: Solène Marie, Irene Hernández-Lozano, Marc Le Vée, Louise Breuil, Wadad Saba, Maud Goislard, Sébastien Goutal, Charles Truillet, Oliver Langer, Olivier Fardel, Nicolas Tournier
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/15/4/392
_version_ 1797434276476616704
author Solène Marie
Irene Hernández-Lozano
Marc Le Vée
Louise Breuil
Wadad Saba
Maud Goislard
Sébastien Goutal
Charles Truillet
Oliver Langer
Olivier Fardel
Nicolas Tournier
author_facet Solène Marie
Irene Hernández-Lozano
Marc Le Vée
Louise Breuil
Wadad Saba
Maud Goislard
Sébastien Goutal
Charles Truillet
Oliver Langer
Olivier Fardel
Nicolas Tournier
author_sort Solène Marie
collection DOAJ
description Endotoxemia-induced inflammation may impact the activity of hepatocyte transporters, which control the hepatobiliary elimination of drugs and bile acids. <sup>99m</sup>Tc-mebrofenin is a non-metabolized substrate of transporters expressed at the different poles of hepatocytes. <sup>99m</sup>Tc-mebrofenin imaging was performed in rats after the injection of lipopolysaccharide (LPS). Changes in transporter expression were assessed using quantitative polymerase chain reaction of resected liver samples. Moreover, the particular impact of pharmacokinetic drug–drug interactions in the context of endotoxemia was investigated using rifampicin (40 mg/kg), a potent inhibitor of hepatocyte transporters. LPS increased <sup>99m</sup>Tc-mebrofenin exposure in the liver (1.7 ± 0.4-fold). Kinetic modeling revealed that endotoxemia did not impact the blood-to-liver uptake of <sup>99m</sup>Tc-mebrofenin, which is mediated by organic anion-transporting polypeptide (Oatp) transporters. However, liver-to-bile and liver-to-blood efflux rates were dramatically decreased, leading to liver accumulation. The transcriptomic profile of hepatocyte transporters consistently showed a downregulation of multidrug resistance-associated proteins 2 and 3 (Mrp2 and Mrp3), which mediate the canalicular and sinusoidal efflux of <sup>99m</sup>Tc-mebrofenin in hepatocytes, respectively. Rifampicin effectively blocked both the Oatp-mediated influx and the Mrp2/3-related efflux of <sup>99m</sup>Tc-mebrofenin. The additive impact of endotoxemia and rifampicin led to a 3.0 ± 1.3-fold increase in blood exposure compared with healthy non-treated animals. <sup>99m</sup>Tc-mebrofenin imaging is useful to investigate disease-associated change in hepatocyte transporter function.
first_indexed 2024-03-09T10:30:53Z
format Article
id doaj.art-27ee7558c859412bb9672fe2db8e091a
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-09T10:30:53Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-27ee7558c859412bb9672fe2db8e091a2023-12-01T21:17:58ZengMDPI AGPharmaceuticals1424-82472022-03-0115439210.3390/ph15040392Pharmacokinetic Imaging Using <sup>99m</sup>Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in RatsSolène Marie0Irene Hernández-Lozano1Marc Le Vée2Louise Breuil3Wadad Saba4Maud Goislard5Sébastien Goutal6Charles Truillet7Oliver Langer8Olivier Fardel9Nicolas Tournier10Université Paris-Saclay, CEA, CNRS, Inserm, Laboratoire d’Imagerie Biomédicale Multimodale, BIOMAPS, Service Hospitalier Frédéric Joliot, 4 Place du Général Leclerc, 91401 Orsay, FranceDepartment of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, AustriaUniv. Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, 35043 Rennes, FranceUniversité Paris-Saclay, CEA, CNRS, Inserm, Laboratoire d’Imagerie Biomédicale Multimodale, BIOMAPS, Service Hospitalier Frédéric Joliot, 4 Place du Général Leclerc, 91401 Orsay, FranceUniversité Paris-Saclay, CEA, CNRS, Inserm, Laboratoire d’Imagerie Biomédicale Multimodale, BIOMAPS, Service Hospitalier Frédéric Joliot, 4 Place du Général Leclerc, 91401 Orsay, FranceUniversité Paris-Saclay, CEA, CNRS, Inserm, Laboratoire d’Imagerie Biomédicale Multimodale, BIOMAPS, Service Hospitalier Frédéric Joliot, 4 Place du Général Leclerc, 91401 Orsay, FranceUniversité Paris-Saclay, CEA, CNRS, Inserm, Laboratoire d’Imagerie Biomédicale Multimodale, BIOMAPS, Service Hospitalier Frédéric Joliot, 4 Place du Général Leclerc, 91401 Orsay, FranceUniversité Paris-Saclay, CEA, CNRS, Inserm, Laboratoire d’Imagerie Biomédicale Multimodale, BIOMAPS, Service Hospitalier Frédéric Joliot, 4 Place du Général Leclerc, 91401 Orsay, FranceDepartment of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, AustriaUniv. Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, 35043 Rennes, FranceUniversité Paris-Saclay, CEA, CNRS, Inserm, Laboratoire d’Imagerie Biomédicale Multimodale, BIOMAPS, Service Hospitalier Frédéric Joliot, 4 Place du Général Leclerc, 91401 Orsay, FranceEndotoxemia-induced inflammation may impact the activity of hepatocyte transporters, which control the hepatobiliary elimination of drugs and bile acids. <sup>99m</sup>Tc-mebrofenin is a non-metabolized substrate of transporters expressed at the different poles of hepatocytes. <sup>99m</sup>Tc-mebrofenin imaging was performed in rats after the injection of lipopolysaccharide (LPS). Changes in transporter expression were assessed using quantitative polymerase chain reaction of resected liver samples. Moreover, the particular impact of pharmacokinetic drug–drug interactions in the context of endotoxemia was investigated using rifampicin (40 mg/kg), a potent inhibitor of hepatocyte transporters. LPS increased <sup>99m</sup>Tc-mebrofenin exposure in the liver (1.7 ± 0.4-fold). Kinetic modeling revealed that endotoxemia did not impact the blood-to-liver uptake of <sup>99m</sup>Tc-mebrofenin, which is mediated by organic anion-transporting polypeptide (Oatp) transporters. However, liver-to-bile and liver-to-blood efflux rates were dramatically decreased, leading to liver accumulation. The transcriptomic profile of hepatocyte transporters consistently showed a downregulation of multidrug resistance-associated proteins 2 and 3 (Mrp2 and Mrp3), which mediate the canalicular and sinusoidal efflux of <sup>99m</sup>Tc-mebrofenin in hepatocytes, respectively. Rifampicin effectively blocked both the Oatp-mediated influx and the Mrp2/3-related efflux of <sup>99m</sup>Tc-mebrofenin. The additive impact of endotoxemia and rifampicin led to a 3.0 ± 1.3-fold increase in blood exposure compared with healthy non-treated animals. <sup>99m</sup>Tc-mebrofenin imaging is useful to investigate disease-associated change in hepatocyte transporter function.https://www.mdpi.com/1424-8247/15/4/392ABC-transporterdrug-induced liver injuryhepatotoxicityorganic anion-transporting polypeptidepharmacokineticsliver function
spellingShingle Solène Marie
Irene Hernández-Lozano
Marc Le Vée
Louise Breuil
Wadad Saba
Maud Goislard
Sébastien Goutal
Charles Truillet
Oliver Langer
Olivier Fardel
Nicolas Tournier
Pharmacokinetic Imaging Using <sup>99m</sup>Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats
Pharmaceuticals
ABC-transporter
drug-induced liver injury
hepatotoxicity
organic anion-transporting polypeptide
pharmacokinetics
liver function
title Pharmacokinetic Imaging Using <sup>99m</sup>Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats
title_full Pharmacokinetic Imaging Using <sup>99m</sup>Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats
title_fullStr Pharmacokinetic Imaging Using <sup>99m</sup>Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats
title_full_unstemmed Pharmacokinetic Imaging Using <sup>99m</sup>Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats
title_short Pharmacokinetic Imaging Using <sup>99m</sup>Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats
title_sort pharmacokinetic imaging using sup 99m sup tc mebrofenin to untangle the pattern of hepatocyte transporter disruptions induced by endotoxemia in rats
topic ABC-transporter
drug-induced liver injury
hepatotoxicity
organic anion-transporting polypeptide
pharmacokinetics
liver function
url https://www.mdpi.com/1424-8247/15/4/392
work_keys_str_mv AT solenemarie pharmacokineticimagingusingsup99msuptcmebrofenintountanglethepatternofhepatocytetransporterdisruptionsinducedbyendotoxemiainrats
AT irenehernandezlozano pharmacokineticimagingusingsup99msuptcmebrofenintountanglethepatternofhepatocytetransporterdisruptionsinducedbyendotoxemiainrats
AT marclevee pharmacokineticimagingusingsup99msuptcmebrofenintountanglethepatternofhepatocytetransporterdisruptionsinducedbyendotoxemiainrats
AT louisebreuil pharmacokineticimagingusingsup99msuptcmebrofenintountanglethepatternofhepatocytetransporterdisruptionsinducedbyendotoxemiainrats
AT wadadsaba pharmacokineticimagingusingsup99msuptcmebrofenintountanglethepatternofhepatocytetransporterdisruptionsinducedbyendotoxemiainrats
AT maudgoislard pharmacokineticimagingusingsup99msuptcmebrofenintountanglethepatternofhepatocytetransporterdisruptionsinducedbyendotoxemiainrats
AT sebastiengoutal pharmacokineticimagingusingsup99msuptcmebrofenintountanglethepatternofhepatocytetransporterdisruptionsinducedbyendotoxemiainrats
AT charlestruillet pharmacokineticimagingusingsup99msuptcmebrofenintountanglethepatternofhepatocytetransporterdisruptionsinducedbyendotoxemiainrats
AT oliverlanger pharmacokineticimagingusingsup99msuptcmebrofenintountanglethepatternofhepatocytetransporterdisruptionsinducedbyendotoxemiainrats
AT olivierfardel pharmacokineticimagingusingsup99msuptcmebrofenintountanglethepatternofhepatocytetransporterdisruptionsinducedbyendotoxemiainrats
AT nicolastournier pharmacokineticimagingusingsup99msuptcmebrofenintountanglethepatternofhepatocytetransporterdisruptionsinducedbyendotoxemiainrats